Impact Factor
3.12
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.04
430 total citations
h5-index
23
h5 depth signal
Cited share
68.5%
152 of 222
Total citations
430
Citation footprint
Metric signal
2.02
External metric anchor
Self-citation
1.2%
5 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
574
China
110
Italy
94
Canada
87
Turkey
78
Citing Fields of Research
Psychiatry
1,012
Psychiatry & Psychology
587
Religion
56
Palliative Care
53
Substance Abuse
52
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
42,307
Articles tracked across the journal lifetime
Indexed publication set
222
152 cited publications
Last 12 months
36
3.6 publications/month
Open access share
11.1%
4 OA publications in the last year
Leading citing country
United States
574 citing publications
Leading citing field
Psychiatry
1,012 citing publications
Latest tracked publication
2 October 2026
10 recent records available
Coverage & Indexing History
v140n6,Jun. 1965-
v140n6,Jun. 1965-
Active Coverage
Active Coverage
Active Coverage
Research Focus & Classification
Indexed Subjects
Psychiatry
Psychiatry & Psychology
Issuing & Sponsoring Bodies
Contributor
American Neurological Association
Contributor
University of Maryland at Baltimore. Psychiatric Institute
Broad Categories
Neurology
Psychiatry
Psychiatry
Psychiatry & Psychology
MeSH Descriptors
Neurology
Psychiatry
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1097/nmd.0000000000001891
Open DOI
Screen Time and Suicidal Behavior
Aim: The widespread use of technology raises concerns about the risks associated with elevated screen time among adolescents. The present study explored whether electronic bullying mediates the relationship between screen time and suicid...
02
DOI 10.1097/nmd.0000000000001877
Open DOI
Tobacco Use Disorder and Co-Occurring Mental Health Conditions
There is a significantly higher prevalence of tobacco use disorder (TUD) among individuals with mental health conditions, and they account for nearly 40% of cigarettes smoked in the United States. Although the DSM-5 notes the high preval...
03
DOI 10.1097/nmd.0000000000001867
Open DOI
Reconceptualizing Substance Use Disorders and Comorbidity
Since 1952, psychiatry has grappled with the concept of addiction in terms of diagnosis, treatment, and research; this work has been particularly complex given the common co-occurrence of other mental health concerns. Tracing the history...
04
DOI 10.1097/nmd.0000000000001880
Open DOI
Advancing Integrated Frameworks for Psychiatric Comorbidity
Was not provided for this article.
05
DOI 10.1097/nmd.0000000000001883
Open DOI
Psychiatric Comorbidity in Research on Medications for Opioid Use Disorder
Introduction: Co-occurring psychiatric conditions are common in opioid use disorder (OUD). This review summarizes findings on the effects of co-occurring conditions on OUD outcomes and changes in psychiatric symptoms during medication tr...
06
DOI 10.1097/nmd.0000000000001898
Open DOI
Supernormal Respondents Report Fewer Immature and Neurotic Defenses Compared to Credible Respondents
Aims: Defense mechanisms are unconscious strategies used to manage anxiety triggered by unpleasant emotions, thoughts, or circumstances. They are commonly assessed through self-report questionnaires, which are known to be susceptible to ...
07
DOI 10.1097/nmd.0000000000001881
Open DOI
Sex and Age Differences in Prevalence of Psychiatric Conditions Comorbid With Substance Use Disorders Among Military Veterans
Aim: Comorbid substance use disorders (SUDs) and mental health (MH) conditions pose unique challenges to veterans’ functioning, quality of life, and treatment. Methods: We characterize comorbidity between SUDs and MH conditions using a s...
08
DOI 10.1097/nmd.0000000000001894
Open DOI
Psychometric Evaluation of the Dimensional Anhedonia Rating Scale (DARS)
Aim: Anhedonia is a transdiagnostic symptom of major depressive disorder (MDD) that is also influenced by substance use, yet the Dimensional Anhedonia Rating Scale (DARS) has only been validated in MDD. This study examined the psychometr...
09
DOI 10.1097/nmd.0000000000001892
Open DOI
A Comparison of Tardive Dyskinesia With First- and Second-Generation Antipsychotics in Postmarket Surveillance Data
Introduction: Tardive dyskinesia (TD) is a known adverse drug reaction (ADR) of first-generation and second-generation antipsychotics. While second-generation antipsychotics are believed to pose a lower TD risk, evidence remains mixed. T...
10
DOI 10.1097/nmd.0000000000001887
Open DOI
Simple to Complex
Aim: The popularity of the Clock Drawing Test (CDT) is paralleled by the multitude of scoring systems ranging from brief and subjective to complex. Methods: To compare the properties and classification accuracy of different scoring appro...
Bibliographical & Catalog Notes
Issues for 1876-96 called also new ser., v. 1-21.
Numbered also 1931?- as no. 589-
Also issued online.
Microfilm. v. 3 (1876)-94 (1941) + Index v. 1 (1874)-50 (1919). 51 microfilm reels : negative ; 35 mm.
Official organ in early years of the American Neurological Association and similar societies.
Issued by the Psychiatric Institute of the University of Maryland, 1958-
Indexes: Vols. 1-50, 1874-1919. 1 v. (Includes index to the journal under its earlier title).
Vol. 183, no. 2 (FEB 1995)19950516 Notice published Printed on acid-free paper